PuraShield: the new medical device for ENT has been launched in Spain

Operating successfully in the Spanish market with its existing flagship products, PuraStat for...

Corporate and “Meet the experts” events: The winning strategy of 3-D Matrix

3-D Matrix continues to be focused on its events strategy with the aim of continuing to develop its...

3-D Matrix boosts its presence in the European market with a full calendar of GI events

The event season for 3-D Matrix is in full swing. Kicking off the series of events this autumn, it...

3-D Matrix Summer Update

3-D Matrix would like to wish you all a wonderful summer and take this opportunity to remind you...

3-D Matrix strengthens its relationship with its distribution partners.

During 3-D Matrix's quarterly European sales meeting, held in Barcelona from the 22nd to the 24th...

Notice regarding the Conclusion of an Agreement Concerning Manufacturing License with FUSO Pharmaceutical Industries, Ltd.

3-D Matrix, Ltd. (headquarters: Chiyoda-ku, Tokyo; President and Representative Director: Jun...

RADA16 use in Plastic surgery (facelift): a pilot study with an optimised application technique

The facelift is one of the most common cosmetic surgeries performed. Although the procedure is...

3-D Matrix keeps aiming in the ENT and Plastic Surgery medical areas with PuraBond

The 3-D Matrix agenda keeps being filled with a selection of events, including those dedicated to...

PuraStat becomes PuraBond for cardiac surgeons in Spain

In conjunction with its participation at the XXVI edition of the Secce’s congress in Oviedo, 3-D...

The Global PuraStat Dinner Grandior Hotel Prague on Thursday 28th April 2022

On Thursday 28th April 2022, 3-D Matrix, in collaboration with FUJIFILM, hosted their first global ...